-
IntroducedJan 05, 2024
-
Passed House
-
Passed Senate
-
Signed into Law
AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- THE PRESCRIPTION DRUG SALES REPRESENTATIVE DISCLOSURE ACT (Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name on list.)
Last Action See all actions
House • Feb 29, 2024: 02/29/2024 Committee recommended measure be held for further study
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on HB 7041
Tweets
Whip Lists
Sponsors
Votes
Actions
- Feb 29, 2024 | House
- 02/29/2024 Committee recommended measure be held for further study
- Feb 23, 2024 | House
- 02/23/2024 Scheduled for hearing and/or consideration (02/29/2024)
- Jan 29, 2024 | House
- 01/29/2024 Committee postponed at request of sponsor (01/30/2024)
- Jan 26, 2024 | House
- 01/26/2024 Scheduled for hearing and/or consideration
- Jan 05, 2024 | House
- 01/05/2024 Introduced, referred to House Health & Human Services
Bill Texts
Documents
- 01/29/2024 Committee postponed at request of sponsor (01/30/2024)
- 02/23/2024 Scheduled for hearing and/or consideration (02/29/2024)
- House Health and Human Services: 02-29-2024--H7041--Department of business RegulationPDF
- House Health and Human Services: 02-29-2024--H7041-H7042-H7140--AHIPPDF
- House Health and Human Services: 02-29-2024--H7041--HDAPDF
- House Health and Human Services: 02-29-2024--H7041--PHRMAPDF
- House Health and Human Services: 01-30-2024--H7041--HDA--Kelly MemphisPDF